Latest News and Press Releases

LONDON and NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...

GBI elects Sumayyah Theron, CEO and Founder of Avant-garde Sustainable Solutions, as Chair of the GBI Board and three new Directors for 2026.

PharmAla inks contract with Ostfold Hospital Trust in Oslo to supply clinical trial in exchange for both cash and a data license

Initial AX-0810 data show no safety signals after 4 weeks of dosing and pharmacokinetics consistent with non-clinical data; Phase 1 enrollment and dosing in healthy volunteers ongoing with target...

Science 37 Named Finalist for 2026 SCOPE Participant Engagement and Site Innovation Awards.

Quanta LOI

Fentanyl designation Response

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- SANDOW Companies announced that it has acquired Azure, Canada’s leading international voice in architecture and design. Azure will operate as part of...

First Patient Dosed with Intranasal Foralumab in Randomized, Placebo-Controlled Phase 2 TrialBuilds on Recent Evidence of Persistent Neuroinflammation in Alzheimer’s Patients Treated with Anti-Amyloid...

MoonLake Immunotherapeutics Hit with Securities Fraud Class Action after Drug Trial Results – Contact BFA Law if You Suffered Losses